Pharmacy benefit management

Pharmacies in Canada, Australia, the U.K. and more can supply Rx medicine for less than half of U.S. prices.

Everybody is playing diversification catch-up to UnitedHealth, which has spent billions on everything from a PBM to ambulatory surgery clinics.

Jeff Bezos has eyed the pharmacy business for years without plunging in. The upside may be too big to ignore.

The new year will see a continuation of the trends from 2017 that have affected employers — but with a sharp focus on insurance company acquisitions and opioid regulations.

Marrying price transparency with strong clinical programs can ensure proper administration of medication based on an individual’s needs.

In the face of specialty drug cost increases, drug chain has created a program to help its sickest customers.

In the face of specialty drug cost increases, drug chain has created a program to help its sickest customers.

Move adds to drug chain’s string of deals in pharma, health and analytics.

Insurer opts instead to build its own such business in collaboration with CVS Health as it looks to contain its spiraling drug costs.

With an anticipated 5% increase in benefits costs, companies are looking to revamp strategies and encourage programs that empower workers to be savvy healthcare consumers.

With an anticipated 5% increase in benefits costs, companies are looking to revamp strategies and encourage programs that empower workers to be savvy healthcare consumers.

Expanding clinical consultations, utilizing available data and studying drug effectiveness are top avenues to plan improvement.

CVS Caremark reports specialty drugs consuming nearly 36% of overall gross spend on prescriptions.

CVS Caremark reports specialty drugs consuming nearly 36% of overall gross spend on prescriptions.

Expanding clinical consultations, utilizing available data and studying drug effectiveness are top avenues to plan improvement.

Health insurer Anthem will drop the pharmacy benefit manager after accusing it of overcharging by billions of dollars a year.

A majority of benefits execs say they were relieved to see the GOP’s healthcare plan fail, and instead would like Congress to focus on drug prices.

A majority of benefits execs say they were relieved to see the GOP’s healthcare plan fail, and instead would like Congress to focus on drug prices.

The push for value-based care is requiring pharmacy benefit managers to provide explicit cost data.